Accepted for/Published in: JMIR Research Protocols
Date Submitted: Mar 26, 2025
Open Peer Review Period: Mar 26, 2025 - May 21, 2025
Date Accepted: Aug 20, 2025
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
CoreDISTparticipation - a comprehensive and structured follow-up for persons with multiple sclerosis to optimize physical functions, health and employment. Protocol for a prospective single-blinded randomized controlled trial and health economic evaluation
ABSTRACT
Background:
Multiple sclerosis (MS) is a chronic neurological disease of the central nervous system primarily affecting young adults. Common challenges in MS include fatigue, physical and cognitive impairments, associated with low levels of physical activity, unemployment, impaired health-related quality of life (HRQoL), substantial personal and societal costs.
Objective:
The purpose of this study is to investigate effects of a comprehensive intervention, CoreDISTparticipation on barriers for work, physical activity, physical functions, fatigue, and HRQoL for employed pwMS and to perform a health-economic evaluation.
Methods:
The prospective, single blinded randomized controlled trial will include 114 pwMS (Expanded Disability Status Scale (0-4)) randomly allocated to the CoreDISTparticipation intervention-group or usual care. CoreDISTparticipation is a multidisciplinary intervention delivered across healthcare levels (hospitals and municipalities) and sectors (health and employment/welfare) including 1) Information videos; hospital outpatient physiotherapist assessment; meeting with employment consultant. 2) Municipality; group-based physiotherapy for 60 minutes, 6 weeks; one indoor CoreDIST-balance session and one outdoor CoreDIST-balance and high-intensity interval session. Tailored work follow-up. 3) 6 weeks of digitally supported independent training x 2 weekly. Assessments at baseline, weeks 9, and 16. Primary outcomes: Multiple Sclerosis Work Difficulties Questionnaire-23 and ActiGraph wGT3x-BT monitors. Secondary outcomes: Trunk Impairment Scale-modified Norwegian Version, Mini-Balance Evaluation Systems Test, AccuGait Optimized force platform, Six-minute walk-test, Multiple Sclerosis Walking Scaleā12, Multiple sclerosis Impact Scale-29 Norwegian version, European Quality of Life 5-Dimension (EQ-5D-5L) and Fatigue Severity Scale.
Results:
The study will identify short- and long-term effects of CoreDISTparticipation versus usual care on work barriers, physical activity, balance, walking, fatigue and quality of life in individuals with minor to moderate MS disability. The project will provide information on health economic factors including the utility of CoreDISTparticipation versus usual care, expressed in quality-adjusted life years, long-term employment status and work-related costs. The statistical analyses will include descriptive statistics and repeated measures mixed models performed in IBM SPSS Version29.
Conclusions:
CoreDISTparticipation is an innovative approach proactively addressing physical function, physical activity, and work participation. If effective, it offers a low-cost approach that potentially may enhance quality of life, workforce sustainability and reduce societal costs. Clinical Trial: ClinicalTrials.gov identifier: NCT06110468
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.